S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
1970’s computer coder issues shocking A.I. warning (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
1970’s computer coder issues shocking A.I. warning (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
1970’s computer coder issues shocking A.I. warning (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
1970’s computer coder issues shocking A.I. warning (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Free Trial

Recordati Industria Chimica e Farmaceutica (RCDTF) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free RCDTF Stock Alerts
$51.60
0.00 (0.00%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RCDTF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCDTF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Recordati Industria Chimica e Farmaceutica Analyst EPS Estimates

Next Year EPS Consensus Estimate: $2.81 EPS

Recordati Industria Chimica e Farmaceutica Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2023Q3 2023-$0.62+$0.62$0.84-$557.14 million
7/28/2023Q2 2023-$0.69+$0.69$0.84-$536.58 million
5/11/2023Q1 2023-$0.81+$0.81$0.98-$591.52 million
3/16/2023Q4 2022-$0.58+$0.58$0.81-$485.80 million
11/8/2022Q3 2022-$0.63+$0.63$0.83-$488.89 million
7/28/2022Q2 2022-$0.56+$0.56$0.84-$504.07 million
5/10/2022Q1 2022-$0.64+$0.64$0.75-$470.63 million
3/17/2022Q4 2021-$0.62+$0.62$0.74-$484.79 million
10/28/2021Q3 2021-$0.59+$0.59$0.67-$454.41 million
7/29/2021Q2 2021-$0.60+$0.60$0.53-$465.09 million
5/6/2021Q1 2021-$0.61+$0.61$0.70-$463.90 million

Recordati Industria Chimica e Farmaceutica Earnings - Frequently Asked Questions

How much revenue does Recordati Industria Chimica e Farmaceutica generate each year?

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded annual revenue of $1.95 billion.

How much profit does Recordati Industria Chimica e Farmaceutica generate each year?

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded net income of $329.08 million. RCDTF has generated $1.93 earnings per share over the last four quarters.

What is Recordati Industria Chimica e Farmaceutica's price-to-earnings ratio?

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a trailing price-to-earnings ratio of 26.74.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (OTCMKTS:RCDTF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Options trading has suddenly become more reliable.
Eagle Publishing
[BUY ALERT] Our #1 A.I. Stock for April
Behind the Markets